---
title: "Mentice gains US FDA 510(k) clearance for Ankyras software"
date: "2024-01-11T16:56:36.000Z"
publishedDate: "11 janvier 2024"
summary: "Mentice recently announced that Ankyras, the company’s clinical decision support application, has received 510(k) clearance from the US Food and Drug Administration (FDA). The approval of this product by the FDA demonstrates the safety and effectiveness of Ankyras, and confirms Mentice’s commitment to providing innovative and high-quality healthcare solutions, as per a company press release."
importance: ""
sourceUrl: "https://interventionalnews.com/mentice-gains-us-fda-510k-clearance-for-ankyras-software/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-01-11-mentice-gains-us-fda-510k-clearance-for-ankyras-software"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/01/Mentice-logo-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/mentice-gains-us-fda-510k-clearance-for-ankyras-software/"
---

![Mentice gains US FDA 510(k) clearance for Ankyras software](https://interventionalnews.com/wp-content/uploads/sites/13/2024/01/Mentice-logo-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/mentice-gains-us-fda-510k-clearance-for-ankyras-software/*

## L’essentiel

Mentice recently announced that Ankyras, the company’s clinical decision support application, has received 510(k) clearance from the US Food and Drug Administration (FDA). The approval of this product by the FDA demonstrates the safety and effectiveness of Ankyras, and confirms Mentice’s commitment to providing innovative and high-quality healthcare solutions, as per a company press release.

## Lien source

https://interventionalnews.com/mentice-gains-us-fda-510k-clearance-for-ankyras-software/
